Characterization of application scenario-dependent pharmacokinetics and pharmacodynamic properties of permethrin and hyperforin in a dynamic skin and liver multi-organ-chip model
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 448, 152637
Abstract
No abstract availableKeywords
Funding Information
- Cosmetics Europe, Brussels, Belgium.
This publication has 66 references indexed in Scilit:
- The Phenion® Full-Thickness Skin Model for Percutaneous Absorption TestingSkin Pharmacology and Physiology, 2009
- Pharmacovigilance: Effects of herbal components on human drugs interactions involving Cytochrome P450Bioinformation, 2008
- Pyrethroids: Cytotoxicity and Induction of CYP Isoforms in Human HepatocytesDrug Metabolism and Drug Interactions, 2008
- INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN’S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURESDrug Metabolism and Disposition, 2004
- Use of human reconstituted epidermis Episkin® for assessment of weak phototoxic potential of chemical compoundsPhotodermatology, Photoimmunology & Photomedicine, 2002
- St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptorProceedings of the National Academy of Sciences, 2000
- Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human VolunteersPharmacopsychiatry, 1998
- LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical TrialPharmacopsychiatry, 1997
- St John's wort for depression—an overview and meta-analysis of randomised clinical trialsBMJ, 1996
- Possible Involvement of the AH Receptor in the Induction of Cytochrome P-450IA1 Under Conditions of Hydrodynamic Shear in Microcarrier-Attached Hepatoma Cell LinesBiochemical and Biophysical Research Communications, 1995